TC Biopharm (Holdings) Plc
TCBPY
$0.3548
$0.039812.64%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.59% | -77.74% | 40.51% | -8.25% | 1.89% |
| Total Depreciation and Amortization | -1.65% | -20.12% | -5.59% | -10.10% | -1.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -5.26% |
| Total Other Non-Cash Items | -1.58% | 17.32% | -84.04% | 164.09% | -1.90% |
| Change in Net Operating Assets | 1.58% | 45.39% | -7,584.43% | -98.40% | -1.90% |
| Cash from Operations | 1.59% | -40.15% | -12.87% | -33.06% | 1.89% |
| Capital Expenditure | 1.44% | -5.70% | -- | -- | -1.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.17% | 20.69% | -63.38% | 71.71% | 1.95% |
| Cash from Investing | 1.62% | 2.37% | -433.80% | -242.00% | -1.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 45.56% | 176.82% | -26.67% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | 100.00% | -109.26% | 0.00% |
| Cash from Financing | -1.59% | 43.39% | 197.23% | -56.17% | -1.89% |
| Foreign Exchange rate Adjustments | 1.48% | -- | -- | -- | 1.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.60% | 366.10% | 101.57% | -656.02% | -1.89% |